Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 19 | Hopman MarkChief Commercial Officer | Open-market sale | SELL | $7,015 370 sh | Oct 5, 2026 |
| 19 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $741K 20.0K sh | Oct 5, 2026 traded Oct 1, 2026 |
| 19 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $727K 20.0K sh | Oct 5, 2026 traded Oct 1, 2026 |
| 19 | DeWitte JacobDirector, Co-Founder, CEO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $727K 20.0K sh | Oct 5, 2026 traded Oct 1, 2026 |
| 19 | Cochran CarolineDirector, Co-Founder, COO, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $741K 20.0K sh | Oct 5, 2026 traded Oct 1, 2026 |
| 16 | Lin MarkEVP and CFO | Open-market sale · 10b5-1 plan | SELL | $173K 967 sh | Oct 5, 2026 traded Oct 1, 2026 |
| 15 | Roth James MChief Revenue Officer | Open-market sale · 10b5-1 plan | SELL | $77K 20.8K sh | Oct 5, 2026 traded Oct 2, 2026 |
| 13 | Chandrasekhar Rao JadcherlaSVP, Products and Services | Open-market sale · 10b5-1 plan | SELL | $35K 6,000 sh | Oct 5, 2026 traded Oct 1, 2026 |
| 12 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.36M 33.0K sh | Oct 5, 2026 traded Oct 1, 2026 |
| 12 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.03M 24.2K sh | Oct 5, 2026 traded Oct 5, 2026 |
| 10 | Robinson Mark HaymondGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $177K 7,296 sh | Oct 5, 2026 traded Oct 1, 2026 |
| 9 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $999K 23.5K sh | Oct 5, 2026 traded Oct 2, 2026 |
| 8 | McGrane AshleyGeneral Counsel and Corp Sec | Open-market sale · 10b5-1 plan | SELL | $9,239 2,461 sh | Oct 5, 2026 traded Oct 2, 2026 |
| 7 | Denier Anthony MichaelDirector, President | Open-market sale · 10b5-1 plan | SELL | $395K 53.8K sh | Oct 5, 2026 traded Oct 5, 2026 |
| 6 | Murray Jason HulseDirector, Co-Founder, CEO & Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $108K 2,596 sh | Oct 5, 2026 traded Oct 2, 2026 |
| 6 | Robinson Mark HaymondGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $99K 3,882 sh | Oct 5, 2026 traded Oct 5, 2026 |
| 32 | Kleinerman ChristianEVP, Product Management | Open-market sale · 10b5-1 plan | SELL | $5.12M 15.0K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 30 | Foundation Fighting Blindness Retinal Degeneration FundDirector, See Remarks | Open-market sale | SELL | $2.76M 556.0K sh | Oct 2, 2026 traded Sep 30, 2026 |
| 27 | Colendich Katie MarieGC, Corporate Secretary | Open-market sale | SELL | $55K 6,318 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 21 | Lee Chan HenrySVP, General Counsel | Open-market sale · 10b5-1 plan | SELL | $418K 1,115 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 21 | Spice Adam C.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $6.05M 85.3K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 21 | Bernstein HaroldPresident, R&D & CMO | Open-market sale · 10b5-1 plan | SELL | $435K 16.1K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 18 | Serafini John SheldonDirector, President and CEO | Open-market sale · 10b5-1 plan | SELL | $1.36M 92.3K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 17 | Spice Adam C.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $2.79M 39.7K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 17 | Spice Adam C.Chief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $1.09M 15.2K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 16 | Gimbel LisaCHIEF ACCOUNTING OFFICER | Open-market sale · 10b5-1 plan | SELL | $9,495 500 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.64M 17.0K sh | Oct 2, 2026 traded Oct 2, 2026 |
| 11 | Sahin UgurChief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $1.66M 17.0K sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $394K 954 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 9 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $766K 1,846 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 7 | Viljoen NataschaDirector, President & CEO | Open-market sale · 10b5-1 plan | SELL | $446K 3,882 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICS | Open-market sale · 10b5-1 plan | SELL | $82K 200 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Schubach Sarah ElizabethChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $66K 2,025 sh | Oct 2, 2026 traded Sep 30, 2026 |
| 6 | Abdelsadek MohamedEVP, Chief Global Solutions | Open-market sale · 10b5-1 plan | SELL | $16K 250 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 6 | Raghavan VaidyanathanChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $56K 549 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 4 | Johnston James DavidExecutive VP, GC, CCO and Secy | Open-market sale · 10b5-1 plan | SELL | $79K 2,600 sh | Oct 2, 2026 traded Oct 1, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $24K 228 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $28K 264 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $25K 247 sh | Oct 2, 2026 traded Oct 2, 2026 |
| 3 | Sahni Sanjeev SinghDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $7,726 74 sh | Oct 2, 2026 traded Oct 2, 2026 |